TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Clinical trials for TRANSFORMED FOLLICULAR LYMPHOMA (TFL) explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED FOLLICULAR LYMPHOMA (TFL) trials appear
Sign up with your email to follow new studies for TRANSFORMED FOLLICULAR LYMPHOMA (TFL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy trial offers hope for patients with aggressive lymphoma
Disease control Recruiting nowThis study is testing a new CAR-T cell therapy called TC011 for adults with aggressive B-cell lymphoma that has come back or hasn't responded to at least two prior treatments. The main goals are to find a safe dose and see if the therapy can shrink or eliminate tumors. It is for …
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test 'Ready-Made' cell therapy for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is an early-stage safety study testing a new type of cell therapy called P-CD19CD20-ALLO1 for adults with aggressive B-cell lymphomas that have come back or not responded to standard treatments. The therapy uses genetically modified immune cells from a donor (not the patient…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC